IGF-1 LR3: Reference Overview and Reconstitution Notes

IGF-1 LR3 research image
For research and educational reference only. Preppin Peppers sells laboratory hardware and materials (reconstitution pens, cartridges, and bacteriostatic water); it does not sell peptides or any substance for consumption. This is educational content, not medical, health, veterinary, dosing, or compounding advice, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure, or prevent any condition, or for human or animal use. Comply with the laws that apply to you and consult a licensed professional for any health decision.

IGF-1 LR3 is a man-made, long-lasting version of a natural protein called insulin-like growth factor 1. It is studied only in laboratory research and is not approved by the FDA.

What it is

IGF-1 LR3 research vial
A research vial of IGF-1 LR3. For educational reference only.

IGF-1 LR3, also written Long R3 IGF-1, is a man-made version of a natural protein called insulin-like growth factor 1. Proteins like this one are built from chains of smaller pieces called amino acids. Think of amino acids as letter beads on a necklace. Scientists changed two things about this particular necklace. First, they swapped one bead at position 3 for a different type called arginine. Second, they added 13 extra beads at one end. Those two changes make it grip certain carrier proteins in the body less tightly, and they let it stay active much longer than the natural version does.


Research context and categorization

IGF-1 LR3 belongs to a group called growth factors. Growth factors are proteins that send "grow and divide" signals to cells. This one is part of the insulin-like growth factor family and is connected to signals triggered by the body's growth hormone. In the lab, researchers study it in relation to cell growth, how cells build new proteins, and muscle and tissue research. Scientists also study how it causes cells to change into specialized types and how it affects the chemical signals that control how cells use energy. All of this work is done in early lab experiments, such as test-tube studies or animal studies, not in people.

Its longer active window compared to natural IGF-1 is the main reason researchers choose it. Think of it like a longer-lasting battery: it is easier to study how a cell responds when a signal stays steady for a longer time. These are lab observations only. They have not been confirmed or approved as effects in people, and this compound is not established as safe or effective for any medical purpose.

Key point: IGF-1 LR3 is a research-only growth factor with a longer active window, designed for early lab studies. It is not approved for use in people.


Status

  • Regulatory status: Research use only. IGF-1 LR3 is not FDA-approved for any purpose and may not be sold as a dietary supplement or drug for human use. The FDA has determined that compounded IGF-1 LR3 does not qualify for the usual compounding exceptions. It is available as a research chemical for in-vitro (test-tube and cell-culture) lab work only.
  • Sport status: Banned under the WADA Prohibited List (the global anti-doping rules for sport). IGF-1 and its man-made versions, including IGF-1 LR3, fall under class S2 (Peptide Hormones, Growth Factors, Related Substances, and Mimetics). They are banned at all times, both during and outside of competition.

Reconstitution notes (general)

Reconstitution concentration is simply how much powder ends up in a set amount of liquid. Divide the milligrams of powder in the vial by the milliliters of liquid you add. For example, a 1 mg vial mixed with 1 mL of liquid gives 1 mg/mL. The same vial mixed with 2 mL gives 0.5 mg/mL. A reconstitution calculator is available at peptide calculator.


Dilution and handling notes (compound-specific)

IGF-1 LR3 arrives as a freeze-dried powder (the technical word is lyophilized). Before lab use, you add liquid to turn it back into a solution. Vials commonly come in sizes such as 0.1 mg and 1 mg. A common lab approach is to add enough liquid to reach roughly 1 mg/mL, though the exact amount depends on what working concentration you need.

Solubility and Acidic Reconstitution

One important quirk with this compound is solubility, which means how well the powder dissolves. IGF-1 LR3 does not always dissolve cleanly in plain bacteriostatic water (water that contains a small amount of preservative to keep it from spoiling). In neutral water it can turn cloudy, look only partly dissolved, or leave a faint haze.

The reason is that this peptide dissolves far more reliably in mildly acidic liquid. Acidity is measured on a scale called pH, which runs from 0 to 14. A pH of 7 is neutral. Lower numbers mean more acidic. A mildly acidic solution puts a tiny electric charge on the outer surface of the molecule, which helps it dissolve. Because of this, many lab protocols first mix IGF-1 LR3 in a dilute acidic liquid, such as weak acetic acid water (imagine a very faint vinegar-like solution, roughly 0.1 to 0.6 percent acid, at a pH near 3) or dilute hydrochloric acid. Once the powder has dissolved, researchers can add more bacteriostatic water if a larger total volume is needed.

If the solution stays cloudy in plain water, that is a sign the liquid is the problem, not the powder. Note that solutions made with acetic acid tend to have a shorter useful life than those made with bacteriostatic water, because acetic acid does not contain the same preservative that keeps bacteriostatic water fresh longer.

Handling Sensitivity

Researchers should follow several key handling steps:

  • Sensitivity to light and oxidation: This peptide can break down when exposed to light or air (a process called oxidation). Keep both the powder and any working solution away from light.
  • Sensitivity to mechanical stress: When adding liquid to the vial, let it run slowly down the inside wall rather than squirting it directly onto the powder. Gently swirl the vial instead of shaking it or using a fast mixer. This reduces foaming and clumping.
  • Freeze-thaw cycling: Avoid freezing and thawing the solution more than once. Repeated freeze-thaw cycles can damage the peptide and lower its quality.

Handling and storage

  • Store the mixed vial in the refrigerator at 2 to 8 degrees Celsius (about 36 to 46 degrees Fahrenheit) and keep it out of light.
  • Wipe the rubber stopper with alcohol before each use.
  • Write the mix date on the vial and plan to use it within roughly four weeks when kept refrigerated.
  • Discard any vial that turns cloudy (beyond a mild haze from the solvent), changes color, or shows floating particles.
  • Keep unmixed freeze-dried powder in the freezer for long-term storage.


Tools and supplies

Macro of IGF-1 LR3 lyophilized powder
Close detail of the lyophilized powder.

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.



Frequently asked questions

What makes IGF-1 LR3 different from natural IGF-1?

Two structural changes , an arginine substitution at position 3 and a 13-amino-acid N-terminal extension , reduce IGF-binding-protein affinity, extending the compound's active window in cell and tissue lab studies.

How do you reconstitute IGF-1 LR3 for laboratory use?

Add bacteriostatic water to the lyophilized powder; divide the vial's mg content by the mL of diluent added to get concentration (e.g., 1 mg ÷ 1 mL = 1 mg/mL). Use a peptide calculator to confirm volumes before use.

What is the regulatory and sport status of IGF-1 LR3?

It is a research chemical for in-vitro use only, is not FDA-approved, and cannot be legally compounded for human use. It is prohibited at all times under WADA Prohibited List class S2. Check applicable local regulations.

What the research community gets wrong about IGF-1 LR3 handling

IGF-1 LR3 trips people up at the reconstitution step more than almost any peptide on the bench. Here are the handling mistakes that show up most often.

  • Reaching for plain bacteriostatic water first. Many researchers assume neutral water dissolves any lyophilized powder. IGF-1 LR3 often stays cloudy or hazy in plain water. It goes into solution far more reliably when a mildly acidic solvent, such as dilute acetic acid or dilute hydrochloric acid, is used first, and more diluent can be added afterward.
  • Throwing out a vial too soon. A faint haze right after adding solvent does not always mean the powder is bad. In the right acidic solvent it can finish dissolving with slow, gentle swirling and a little patience. Discard for a true problem, like a strong cloud, a color change, or floating bits, not for a brief haze.
  • Shaking to speed things up. Fast shaking foams the liquid, and the air-to-liquid surface is where proteins tend to clump. Let the solvent run down the inner glass wall and swirl slowly instead.
  • Treating an acid-made solution like it lasts as long as one made in bacteriostatic water. Acetic acid solvent has no preservative, so a solution made with it has a shorter useful window. Plan around that instead of reusing it for weeks.
  • Underrating light and freeze-thaw. Leaving the vial out in room light or refreezing leftover solution breaks the peptide down faster than people expect. Keep it dark, keep it cold, and avoid repeat freeze-thaw cycles.

From our bench: when we pressure-test our reconstitution pens and glass cartridges with practice solutions, the cloudy-then-clear pattern researchers describe with neutral water matches what we see with our own hardware. The fluid clears once the solvent chemistry is right, not by mixing harder, and letting the diluent slide down the inner wall with a slow swirl gives a cleaner draw through the pen than any quick shake.


Sources

  1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
  2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
  3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
  4. UniProt P05019 , Insulin-like growth factor 1 (human), gene IGF1, 195 aa (parent protein of the LR3 analog)
  5. Dunaiski V, Dunshea FR, Walton PE, Goddard C. Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs. J Endocrinol. 1997;155(3):559-65 (PMID 9488001)

✔ Reviewed by Bryan Le, PharmD, RPh

Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.

Get more of The Lab in your Google results
Browse The Lab by topic